Boston Scientific Corp. (BSX)
Health Care ยท Surgical & Medical Instruments & Apparatus
Boston Scientific Corp. (BSX) is listed on the New York Stock Exchange, where its shares have traded since May 18, 1992. SentiSense covers Boston Scientific Corp. in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus. Michael Mahoney is its chief executive officer. The company reports 59,000 employees, and its corporate website is www.bostonscientific.com.
About Boston Scientific Corp.
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Latest reported results
Boston Scientific Corporation reported revenue of $5.14 billion for Q3 FY2026, up 1.4% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1,455 institutions reported holding BSX, with 1.3 billion shares worth $56.7 billion in aggregate. The largest reported holders were Vanguard, BlackRock and State Street. Of the 5 largest reported holders, 3 added shares and 2 reduced their positions during the quarter.
More on BSX
- BSX sentiment: whether news and social coverage of Boston Scientific Corp. leans bullish or bearish, and the stories driving it.
- BSX ownership: all 1,455 reporting institutions, plus insider and congressional trades.
- BSX financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for Boston Scientific Corp.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Boston Scientific Corp. do?
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts.
What sector is BSX in?
SentiSense classifies Boston Scientific Corp. in the Health Care sector, and its Standard Industrial Classification is Surgical & Medical Instruments & Apparatus.
Where does BSX stock trade?
Boston Scientific Corp. (BSX) is listed on the New York Stock Exchange, where its shares have traded since May 18, 1992.
Who is the CEO of Boston Scientific Corp.?
Michael Mahoney is the chief executive officer of Boston Scientific Corp..